Qiming Venture Partners's Biotechnology Portfolio

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Fasikl is a neuro-AI company that creates interfaces for the nervous system.

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Powering precision proteomics to enable to the earliest detection of disease.

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

CSR Biotech is a biological research company that provides cell imaging and data processing services.

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

PRCXI Biotechnology is a biotech company that focuses on analytical instruments, bioinformatics and automation solutions for life sciences.

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases.

ChemLex is a chemical synthesis CRO that was founded by Magera Technology.

Vybio is a high-tech enterprise focusing on innovative drug research and development.

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.

Brise Pharma operates in the scientific research and technical service industry.

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.

LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.

Yuyao Bio is an innovative drug research and development company.

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.